Document
type: Class

Lupus
type: Journal
type: Entity
publication venue for: Recurrent diffuse alveolar haemorrhage in a patient with systemic lupus erythematosus: Long-term benefit of rituximab
type: Thing
type: Document
type: Continuant
type: Generically Dependent Continuant
type: Periodical
type: Collection
type: Information Content Entity

Continuant
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

RDF description of Recurrent diffuse alveolar haemorrhage in a patient with systemic lupus erythematosus: Long-term benefit of rituximab - http://orbis.uaslp.mx/vivo/individual/scopus3169
rights: termsOfUse
date: 2026-08-24T21:51:22
publisher: vivo
type: Document

Recurrent diffuse alveolar haemorrhage in a patient with systemic lupus erythematosus: Long-term benefit of rituximab
issue: 10
e iscopus: 2-s2.0-84865092539
estado: published
type: Document
volume: 21
type: Generically Dependent Continuant
type: Entity
freetext keyword: diffuse alveolar haemorrhage; rituximab; systemic lupus erythematosus amlodipine; azathioprine; beta adrenergic receptor blocking agent; cyclophosphamide; enalapril; hemoglobin; methotrexate; methylprednisolone; mycophenolic acid 2 morpholinoethyl ester; neutrophil cytoplasmic antibody; prednisone; rituximab; abdominal pain; adult; anamnesis; article; artificial ventilation; cachexia; case report; cell infiltration; computer assisted tomography; cryoglobulinemia; diffuse alveolar hemorrhage; disease activity; female; follow up; hemoptysis; human; hypertension; hypoxemia; immunosuppressive treatment; impedance; kidney biopsy; long term care; lung alveolus; lung hemorrhage; lung lavage; nuclear magnetic resonance imaging; posterior reversible encephalopathy syndrome; priority journal; recurrent disease; systemic lupus erythematosus; vasculitis; Antibodies, Monoclonal, Murine-Derived; Cachexia; Female; Hemorrhage; Humans; Immunosuppressive Agents; Lung Diseases; Lupus Erythematosus, Systemic; Posterior Leukoencephalopathy Syndrome; Pulmonary Alveoli; Recurrence; Young Adult
page start: 1124
date time value: article date 3170
type: Thing
type: Continuant
doi: 10.1177/0961203312444171
type: Article
abstract: Diffuse alveolar haemorrhage (DAH) is an uncommon complication of systemic lupus erythematosus (SLE), and recurrences of DAH with remission periods are unusual. We describe a young woman with cachexia as the initial manifestation of SLE who presented posterior reversible encephalopathy syndrome (PRES), intestinal vasculitis and four episodes of DAH even though she was receiving combined immune suppressive therapy. After treatment with rituximab (RTX) the patient has not presented further episodes of DAH. © 2012 The Author(s).
origen: scopus
pmid: 22460294
most specific type: Article
has publication venue: Lupus
type: Information Content Entity
related by: authorship_18444
chemicalscas: amlodipine, 103129-82-4, 736178-83-9, 88150-42-9; azathioprine, 446-86-6; cyclophosphamide, 50-18-0; enalapril, 75847-73-3; hemoglobin, 9008-02-0; methotrexate, 15475-56-6, 59-05-2, 7413-34-5; methylprednisolone, 6923-42-8, 83-43-2; mycophenolic acid 2 morpholinoethyl ester, 116680-01-4, 128794-94-5; prednisone, 53-03-2; rituximab, 174722-31-7; Antibodies, Monoclonal, Murine-Derived; Immunosuppressive Agents; rituximab
crisid: 3170
related by: authorship_18443
most specific type: Document
page end: 1127

Article
type: Class

Information Content Entity
type: Class